SCHEMBL17228496

SCHEMBL17228496

NC1CCNC12CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10800937 0.87 ALDH1A1 (0.33) —
Hydrochloric Acid SCHEMBL25394135 0.85 ALDH1A1 (0.32) —
SCHEMBL19898324 0.77 — —
SCHEMBL16914285 0.75 — —
SCHEMBL13681785 0.67 — —
Hydrochloric Acid SCHEMBL31208723 0.65 — —
SCHEMBL23420847 0.65 — —
SCHEMBL25151490 0.58 — —
SCHEMBL24139829 0.58 — —
SCHEMBL24231383 0.58 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024516-A1 ISOQUINOLINONE DERIVATIVES SERVING AS ROCK PROTEIN KINASE INHIBITORS AND USE THEREOF GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO., LTD. (CN) 2023-01-26 — — US disclosed
WO-2020253882-A1 ISOQUINOLINONE DERIVATIVES SERVING AS ROCK PROTEIN KINASE INHIBITORS AND USE THEREOF 中山大学中山眼科中心 2020-12-24 — — WO disclosed
EP-3138843-A1 ISOQUINOLINESULFONYL DERIVATIVE AS RHO KINASE INHIBITOR Medshine Discovery Inc. (CN) 2017-03-08 — — EP disclosed
WO-2015165341-A1 ISOQUINOLINESULFONYL DERIVATIVE AS RHO KINASE INHIBITOR 南京明德新药研发股份有限公司 2015-11-05 — — WO disclosed
Send feedback